BioCentury
ARTICLE | Company News

Epimmune names new president, CEO

January 18, 2001 8:00 AM UTC

EPMN, a developer of cellular immunity vaccines for cancer and infectious diseases, hired Emile Loria as president, CEO and a director. Prior, he was president and CEO of vaccine company Biovector The...